Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BioVie ( (BIVI) ) has provided an update.
BioVie Inc., a clinical-stage company developing treatments for chronic conditions, has successfully closed a direct offering and private placement, raising approximately $6 million. The funds will be primarily used for working capital and general corporate purposes. This strategic financial move reflects BioVie’s ongoing commitment to advancing its innovative drug therapies, including those for neurodegenerative disorders and liver disease, amidst market uncertainties and potential risks.
See more insights into BIVI stock on TipRanks’ Stock Analysis page.
